Literature DB >> 8307037

Genuine and apparent cross-reaction of polyclonal antibodies to proteins and peptides.

L Leder1, H Wendt, C Schwab, I Jelesarov, S Bornhauser, F Ackermann, H R Bosshard.   

Abstract

Antiserum to a native protein may cross-react with the corresponding denatured protein or with peptides. The cross-reaction is either a genuine property of the antibodies or caused by antibodies produced against some unfolded protein contaminating the native protein used for immunization. Appropriate conformation-sensitive immunoassays must be employed to distinguish a genuine from an apparent cross-reaction. In the present study, we have analyzed critically the cross-reaction of rabbit antisera against proteins and peptides. We have distinguished between genuine and apparent cross-reaction with the help of the protein A antibody-capture ELISA, a new conformation-sensitive ELISA format. Three systems were analyzed: cross-reaction of antisera to native yeast and horse cytochrome c with unfolded apo-cytochrome c; cross-reaction of antisera to a coiled-coil leucine-zipper peptide with a homologous random-coil peptide obtained by introducing two proline residues into the leucine-zipper sequence; cross-reaction of antisera to two peptides that correspond to the N-terminal and an internal sequence of ferredoxin: NADP+ reductase (FNR), with the native enzyme. The reaction of the anti-(cytochrome c) sera was clearly due to antibodies produced against unfolded protein, it was an apparent and not a genuine cross-reaction. Furthermore, the apparently cross-reactive antibodies to horse cytochrome c did not discriminate against sequence-related proteins from dog, beef, rabbit and pigeon. In contrast, antibodies to the leucine-zipper peptide did cross-react in a genuine way with the homologous random-coil peptide, that is, the cross-reactive antibodies do not seem to have been produced against the unfolded form of the leucine-zipper peptide. Of the two anti-peptide sera the one against the unstructured and highly accessible N-terminal segment reacted strongly with the native protein. The second serum against a solvent-accessible turn-like sequence of FNR showed apparent cross-reactivity: antibodies recognizing the native protein were directed against a minor conformational isoform of the free peptide and did not react with the principal form(s) of the free peptide. The generation of cross-reactive antibodies depends on the conformational stability and integrity of the immunogen and on the molecular form of its application, i.e., free, polymerized or carrier-bound. The results clarify the different nature of cross-reactivity of antisera to proteins and peptides. This knowledge is crucial if antisera are to be used as conformation-specific probes.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8307037     DOI: 10.1111/j.1432-1033.1994.tb19916.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  5 in total

1.  The central variable V2 region of the CS31A major subunit is involved in the receptor-binding domain.

Authors:  P Di Martino; J P Girardeau; M Der Vartanian; B Joly; A Darfeuille-Michaud
Journal:  Infect Immun       Date:  1997-02       Impact factor: 3.441

2.  Characterization of leucine zipper complexes by electrospray ionization mass spectrometry.

Authors:  H Wendt; E Dürr; R M Thomas; M Przybylski; H R Bosshard
Journal:  Protein Sci       Date:  1995-08       Impact factor: 6.725

Review 3.  Benchmarking B-cell epitope prediction for the design of peptide-based vaccines: problems and prospects.

Authors:  Salvador Eugenio C Caoili
Journal:  J Biomed Biotechnol       Date:  2010-03-30

4.  Optimization of fluorophores for chemical tagging and immunohistochemistry of Drosophila neurons.

Authors:  Geoffrey W Meissner; Jonathan B Grimm; Rebecca M Johnston; Ben Sutcliffe; Julian Ng; Gregory S X E Jefferis; Sebastian Cachero; Luke D Lavis; Oz Malkesman
Journal:  PLoS One       Date:  2018-08-15       Impact factor: 3.240

5.  Benchmarking B-cell epitope prediction with quantitative dose-response data on antipeptide antibodies: towards novel pharmaceutical product development.

Authors:  Salvador Eugenio C Caoili
Journal:  Biomed Res Int       Date:  2014-05-11       Impact factor: 3.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.